Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 18%
Buy 29%
Hold 53%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is a leader in the medical technology industry, with a diverse portfolio of imaging, visualization, and patient care solutions that make up almost 90% of their revenue. The remaining recurring revenue from servicing, pharmaceutical diagnostics, and digital solutions provides stability. Despite some potential challenges and regulatory compliance issues, their focus on innovation, recent acquisitions, and global expansion make them a strong investment opportunity with potential for growth in the future.

Bears say

GE HealthCare Techs is facing significant challenges in the short term due to tariffs and inflation, as well as competition in the total-body imaging market from traditional rivals and new entrants. Although the company has a strong focus on innovation and R&D, as well as a diverse geographic revenue mix, it may struggle to maintain its EBIT margin in the face of these challenges. Additionally, while they have recently introduced new products and technologies, the success of these launches and partnerships is uncertain in the highly competitive medical technology industry.

GEHC has been analyzed by 17 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 29% recommend Buy, 53% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 17 analysts, GEHC has a Buy consensus rating as of Jul 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.